为成年人提供数字喘自我管理计划:一项随机临床试验
Jordan Silberman1, Siavash Sarlati2,3, Bronwyn Harris4
1Office of Medical Policy and Technology Assessment, Elevance Health Inc, Palo Alto, California.
JAMA network open
|July 17, 2025
概括
与通常护理相比,数字喘自我管理 (DASM) 计划改善了成年人的喘控制. 进一步的适应可能会在不同患者群体中增强益处.
科学领域:
- 数字健康数字健康
- 喘管理的管理
- 临床试验中的临床试验.
背景情况:
- 数字健康技术显示出改善喘自我管理的前景.
- 关于数字喘自我管理计划有效性的证据有限.
- 成人喘自我管理需要创新和可访问的解决方案.
研究的目的:
- 调查数字喘自我管理 (DASM) 计划对成年人喘症状的影响.
- 评估基于应用程序的干预措施对改善喘控制的有效性.
- 评估DASM程序对患者报告结果的影响.
主要方法:
- 进行了一项随机,实用,并行臂,开放标签,分散的临床试验.
- 患有喘的成年人被随机分配到DASM计划或常规护理中.
- 该DASM程序包括量身定制的通知,症状记录和可穿戴设备集成.
主要成果:
- 与通常护理相比,在基线时患有非控制性喘的参与者在DASM计划的喘控制测试 (ACT) 成绩显著改善 (2.8点差异,P<.001).
- DASM计划对喘控制的积极影响在不认同非洲裔美国人的参与者中更为明显.
- 根据保险状况或种族,没有观察到DASM计划效应的显著缓解.
结论:
- 在一项随机试验中,数字喘自我管理 (DASM) 计划表明,与通常护理相比,喘控制得到了改善.
- 这些发现表明,数字健康干预可以有效地支持喘自我管理.
- 程序的调整可能是必要的,以确保在不同的患者群体中获得公平的利益.
更多相关视频
相关概念视频
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300


